MPS Limited — Board Meeting, 02-02-2026: Outcome of Board Meeting

MPS Limited's Board approved Q3 & 9M consolidated results, with revenue reaching ₹2099.26 Cr and PAT ₹110 Cr for the nine months. Key strategic moves include a subsidiary acquiring Unbound Medicine for $16.5M and another completing the Liberate Group acquisition. Ms. Yamini Tandon also resigned as Non-Executive Director.